Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Journal Mobile Options
Table of Contents
Vol. 20, No. 1, 2011
Issue release date: December 2010
Section title: Original Paper
Open Access Gateway
Med Princ Pract 2011;20:51–59
(DOI:10.1159/000319547)

Assessment of the Stability of Novel Antibacterial Triazolyl Oxazolidinones Using a Stability-Indicating High-Performance Liquid Chromatography Method

Phillips O.A. · Sharaf L.H. · Abdel-Hamid M.E. · Varghese R.
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kuwait University, Jabriya, Kuwait
email Corresponding Author

Oludotun A. Phillips

Department of Pharmaceutical Chemistry, Faculty of Pharmacy

Kuwait University, PO Box 24923

Safat 13110 (Kuwait)

Tel. +965 2498 6070, Fax +965 2534 2807, E-Mail dphillips@hsc.edu.kw


References

  1. Grau S, Rubio-Terrés C: Pharmacoeconomics of linezolid. Expert Opin Pharmacother 2008;9:987–1000.
  2. Drew RH: Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections. Pharmacotherapy 2007;27:227–249.
  3. Wilcox MH: Update on linezolid: the first oxazolidinone antibiotic. Expert Opin Pharmacother 2005;6:2315–2326.
  4. Moellering RC: Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med 2003;138:135–142.
  5. Bozdogan B, Appelbaum PC: Oxazolidinones: activity, mode of action, and mechanism of resistance. Int J Antimicrob Agents 2004;23:113–119.
  6. Sinclair A, Arnold C, Woodford N: Rapid detection and estimation by pyrosequencing of 23S rRNA genes with a single nucleotide polymorphism conferring linezolid resistance in Enterococci. Antimicrob Agents Chemother 2003;47:3620–3622.
  7. Ippolito JA, Kanyo ZF, Wang D, Franceschi FJ, Moore PB, Steitz TA, Duffy EM: Crystal structure of the oxazolidinone antibiotic linezolid bound to the 50S ribosomal subunit. J Med Chem 2008;51:3353–3356.
  8. Tsiodras S, Gold HS, Sakoulas G, Eliopoulos GM, Wennersten C, Venkataraman L, Moellering RB Jr, Ferraro MJ: Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 2001;358:207–208.
  9. Johnson AP, Tysall L, Stockdale MW, Woodford N, Kaufmann ME, Warner M, Livermore DM, Asboth F, Allerberger FJ: Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit. Eur J Clin Microbiol Infect Dis 2002;21:751–754.
  10. Jones RN, Kohno S, Ono Y, Ross JE, Yanagihara K: ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5,591 Gram-positive clinical isolates in 23 countries. Diagn Microbiol Infect Dis 2009;64:191–201.
  11. Phillips OA, Udo EE, Ali AAM, Al-Hassawi N: Synthesis and antibacterial activity of 5-substituted oxazolidinones. Bioorg Med Chem 2003;11:35–41.
  12. Phillips OA, Udo EE, Ali AAM, Samuel SM: Synthesis and antibacterial activity of new N-linked 5-triazolylmethyl oxazolidinones. Bioorg Med Chem 2005;13:4113–4123.
  13. Phillips OA, Udo EE, Ali AAM, Samuel SM: Structure-antibacterial activity of arylcarbonyl- and arylsulfonyl-piperazine 5-triazolylmethyl oxazolidinones. Eur Med Chem 2007;42:214–225.
  14. Phillips OA, Udo EE, AbdelHamid ME, Varghese R: Synthesis and antibacterial activity of novel 5-(4-methyl-1H-1,2,3-triazole)methyl oxazolidinones. Eur Med Chem 2009;44:3217–3227.
  15. Reck F, Zhou F, Girardot M, Kern G, Eyermann CJ, Hales NJ, Ramsay RR, Gravestock MB: Identification of 4-substituted 1,2,3-triazoles as novel oxazolidinone antibacterial agents with reduced activity against monoamine oxidase A. J Med Chem 2005;48:499–506.
  16. Hauck SI, Cederberg C, Doucette A, Grosser L, Hales NJ, Poon G, Gravestock MB: New carbon-linked azole oxazolidinones with improved potency and pharmacokinetics. Bioorg Med Chem Lett 2007;17:337–340.
  17. Phillips OA, Abdel-Hamid ME, Al-Hassawi N: Determination of linezolid in human plasma by LC-MS-MS. Analyst 2001;126:609–614.
  18. Slatter JG, Stalker DJ, Feenstra KL, Welshman IR, Bruss JB, Sama JP, Johnson MG, Sanders PE, Hauer MJ, Fagerness PE, Stryd RP, Peng GW, Shobe EM: Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [14C] linezolid to healthy human subjects. Drug Metab Dispos 2001;29:1136–1145.
  19. Ji HY, Lee HW, Chang SG, Lee JJ, Rhee JK, Kim WB, Lee HS: Liquid chromatography-tandem mass spectrometry for the determination of a new oxazolidinone antibiotic DA-7867 in human plasma. Biomed Chromatogr 2004;18:86–89.
  20. Phillips OA, Abdel-Hamid ME: Determination of novel triazolylmethyl oxazolidinone concentrations in human plasma by APCI-LC-MS: application to stability study. J Pharmaceut Sci 2008;11:22s–31s.
  21. Greene TW, Wuts PGM: Protective Groups in Organic Synthesis, ed 3. New York, Wiley, 1999, chapt 7, pp 503–550.